Market Recap: Dow Edges Higher as S&P and Nasdaq Slide; Spotify Surges 14.75% on Earnings, Quince Therapeutics Jumps 305.92%

The U.S. market closed mixed on February 10, 2026, as the Dow Jones Industrial Average edged up 0.104% to $50,188.14, while the S&P 500 fell 0.33% to $6,941.81 and the Nasdaq Composite dropped 0.586% to $23,102.47. Commodities underperformed, with WTI crude oil down 0.311% to $64.16, gold futures falling 0.612% to $5,048.30, and silver futures plunging 2.054% to $80.545. Sector-wise, Utilities (+1.14%) and Real Estate (+1.23%) led gains, while Energy (-0.29%) and Information Technology (-0.30%) lagged. The mixed tone reflected uncertainty over Fed policy and AI-driven sector volatility.

Hot Stocks

Tech Giants:

• Spotify (SPOT): +14.75%
• Datadog (DDOG): +13.74%
• Nvidia (NVDA): -0.79%
• Apple (AAPL): -0.34%
• Microsoft (MSFT): -0.08%

Chinese ADRs:

• Tian Ruixiang (TIRX): -15.98%
• Ming Shing Group (MSW): +13.89%
• Jiuzi Holdings (JZXN): +89.71%

Biotech & Retail:

• Quince Therapeutics (QNCX): +305.92%
• Quest Diagnostics (DGX): +7.37%
• Hasbro (HAS): +7.48%

Industrial & Consumer:

• Masco (MAS): +8.67%
• Toll Brothers (TOL): +5.92%
• Hyatt Hotels (H): +5.90%

Analysts Opinions

Analysts highlighted diverging trends: UBS downgraded the U.S. tech sector to "neutral" due to AI-driven disruption risks, while Morgan Stanley warned of potential credit market strain from software sector volatility. Freshworks’ AI-driven revenue forecast above estimates underscored optimism in enterprise software, contrasting with Ford’s $8 billion net loss and EV unit struggles. The Vatican Bank’s new Catholic-themed indexes signaled growing ESG demand, while U.S. retail sales flatness fueled expectations of Fed rate cuts.

Macro & Corporate News

1. Flat December Retail Sales Fuel Fed Rate Cut Bets

December retail sales remained unchanged, missing expectations of a 0.4% rise. The weak data intensified speculation of Fed rate cuts in 2026, with over 75% of traders now pricing in cuts by June. Treasury yields fell sharply as investors priced in accommodative policy.

2. AI-Driven Software Selloff Spreads Fears

UBS warned that AI disruption risks could impact the $1.5 trillion U.S. credit market, with 50% of software loans rated "B- or lower." The sector’s selloff, dubbed the "SaaSpocalypse," saw Rapid7 and Robinhood underperform despite revenue growth.

3. Vatican Bank Launches Catholic-Principled Indexes

The Vatican Bank partnered with Morningstar to launch two equity indexes (U.S. and Eurozone) featuring 50 companies aligned with Catholic values. The move reflects growing demand for faith-based investing amid ESG outflows.

4. Ford’s EV Woes Deepen

Ford reported a $11.1 billion Q4 loss and a $8.2 billion annual loss, driven by $12.5 billion in EV unit charges. CEO Jim Farley warned of $4–4.5 billion in 2026 EV losses, signaling ongoing challenges in the transition to electric vehicles.

5. Quince Therapeutics’ 305.92% Surge

The biotech stock jumped on a 305.92% gain after reporting $277.4 million in Q4 revenue and raising 2026 guidance. The surge highlighted speculative fervor in the sector, with other biotechs like Evommune (EVMN) and TuHURA Biosciences (HURA) also surging.

6. Delayed January Jobs Report Looms

The delayed January nonfarm payrolls report, expected to show minimal job growth or even zero net gains, will clarify labor market trends. Economists warn of potential job losses and AI-driven productivity gains, with the Fed prioritizing inflation over unemployment in its policy calculus.